Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm
30 oct. 2024 09h30 HE
|
KUEHN LAW, PLLC
Kuehn Law Encourages PFIE, GLYC, RVNC, and RCM Investors to Contact Law Firm
Kuehn Law Encourages ZUO, ARC, K, and RVNC Investors to Contact Law Firm
18 oct. 2024 09h17 HE
|
KUEHN LAW, PLLC
Kuehn Law Encourages ZUO, ARC, K, and RVNC Investors to Contact Law Firm
Revance Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm
03 nov. 2021 11h21 HE
|
Portnoy Law
LOS ANGELES, Nov. 03, 2021 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Revance Therapeutics, Inc. ("Revance" or the "Company") (NASDAQ: RVNC) investors that the firm has initiated an...